ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Inventiva

Inventiva (IVA)

2.16
0.00
(0.00%)
마감 30 1월 1:30AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
2.16
매수가
2.155
매도가
2.17
거래량
0.00
0.00 일간 변동폭 0.00
1.434 52주 범위 4.30
market_cap
전일 종가
2.16
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
22,254
발행 주식
210,670,845
배당수익률
-
주가수익률
-4.12
주당순이익(EPS)
-0.52
매출
23.16M
순이익
-110.43M

Inventiva 정보

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
본부
Daix, Fra
설립됨
-
Inventiva is listed in the Biological Pds,ex Diagnstics sector of the 유로넥스트 (Euronext) with ticker IVA. The last closing price for Inventiva was 2.16 €. Over the last year, Inventiva shares have traded in a share price range of 1.434 € to 4.30 €.

Inventiva currently has 210,670,845 shares in issue. The market capitalisation of Inventiva is 455.05 € million. Inventiva has a price to earnings ratio (PE ratio) of -4.12.

IVA 최신 뉴스

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients atteints de DT2 et MASLD

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients...

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of...

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

As previously reported1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance...

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), New York City (New York, Etats-Unis), le 24 janvier 2025 – Inventiva (Euronext Paris...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA...

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 Daix (France), New York City (New York...

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025 Daix (France), New York City (New...

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company...

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.05-2.262443438912.212.7052.155689722.40749617DE
4-0.03-1.36986301372.192.7052.08263632.32376859DE
12-0.28-11.47540983612.442.7052222542.3517573DE
26-0.03-1.36986301372.193.21.434378912.28468515DE
52-1.42-39.66480446933.584.31.434453832.79298946DE
156-8.54-79.813084112110.7121.434537793.72284405DE
260-1.94-47.31707317074.116.31.434627327.11338164DE

IVA - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?
The current share price of Inventiva is 2.16 €
How many Inventiva shares are in issue?
Inventiva has 210,670,845 shares in issue
What is the market cap of Inventiva?
The market capitalisation of Inventiva is EUR 455.05M
What is the 1 year trading range for Inventiva share price?
Inventiva has traded in the range of 1.434 € to 4.30 € during the past year
What is the PE ratio of Inventiva?
The price to earnings ratio of Inventiva is -4.12
What is the cash to sales ratio of Inventiva?
The cash to sales ratio of Inventiva is 19.65
What is the reporting currency for Inventiva?
Inventiva reports financial results in EUR
What is the latest annual turnover for Inventiva?
The latest annual turnover of Inventiva is EUR 23.16M
What is the latest annual profit for Inventiva?
The latest annual profit of Inventiva is EUR -110.43M
What is the registered address of Inventiva?
The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121
What is the Inventiva website address?
The website address for Inventiva is www.inventivapharma.com
Which industry sector does Inventiva operate in?
Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
littlejohn littlejohn 4 분 전
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 5 분 전
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 7 분 전
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 8 분 전
Thanks for the input...
ALYI
littlejohn littlejohn 15 분 전
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 16 분 전
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 18 분 전
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 18 분 전
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
dinogreeves dinogreeves 22 분 전
SMCI after the report it will get to the right valuation with time.
SMCI
dinogreeves dinogreeves 23 분 전
DeepSeek is fake.
SMCI
toogoodfella toogoodfella 24 분 전
IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
YOULL BECOME VERY FAMOUS

LEHNQ
trader53 trader53 25 분 전
DPLS 0.0004 - Point of Maximum Financial Opportunity


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________
DPLS MFI
fuagf fuagf 28 분 전
Just hearing of it now on our news. Terrible!!!
Susie924 Susie924 28 분 전
There wasn’t much to hear but there was definitely a gasp at one point.
Kool Aid Man Kool Aid Man 29 분 전
Shieldcom's only 'contact' is a mail drop at their registered agent's office --Corporation Trust Center in Delaware. 'In 2012, it was the registered agent address of at least 285,000 separate American and foreign businesses who operate or trade in the United States'
https://en.wikipedia.org/
MONI
jjmentat jjmentat 32 분 전
Did you try Ebay??????
You know what they say........If you can't get it on Ebay or Walmart.......you're out of luck.......LOL
Fredddddy Fredddddy 32 분 전
Yes. I had been waiting on a good spot. Unfortunately came down with stomach bug Tuesday. (Thank you children). So I’m just getting back to level. And I missed it. On side lines waiting for entry.
XMaster2023 XMaster2023 33 분 전
Approval Tomorrow? It’s time!
NWBO
blackcat blackcat 33 분 전
Thanks- for some reason it won't load. I'll try it on my other laptop later.
"Something went wrong. Try reloading".
Ray_137 Ray_137 37 분 전
April fool's day! Like tons of other predictions.
COOP
noradio noradio 43 분 전
Why should a US listed company, that's fully reporting and audited and has disclosed all it needs to disclose. Be halted because Canadian regulators need a vote?
TWOH
jeunke22 jeunke22 46 분 전
Here is an interesting article on Apple and GAI confirming your opinion. The market for speed bandwidth, low latency and small form factor of optical engines over fiber connections will take another leap forward.
https://www.techradar.com/pro/apple-is-the-biggest-winner-of-deepseeks-new-ai-b
LWLG
cottonisking cottonisking 46 분 전
We are waiting on a SCOTUS ruling on AGFP/LBIE friends of the Courts ruling. From a NYU Professor and Deutsch Bank.

Go back and study the text in the Series P prospectus that I posted.

You make me laugh 😂.

Good luck Buddy.
LEHNQ

최근 히스토리

Delayed Upgrade Clock